Previous 10 | Next 10 |
WOBURN, Mass., May 14, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three months ended March 31, 2020. “In the first quarter, we prioritized focus on activities relating to our 2020 Fi...
WOBURN, Mass., May 14, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company has secured all of the regulatory permits required to conduct field tests for multiple traits at sites in the United States and Canada...
WOBURN, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN), an agricultural bioscience company, announced today that the Company will report its first quarter 2020 financial results and provide a corporate update on Thursday, May 14, 2020. Management will hos...
WOBURN, Mass., May 06, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, announced today a change in the format of its Annual Meeting of Shareholders ("Annual Meeting") from an in-person to a virtual-only meeting, via webcast, due to ...
NeuBase Therapeutics (NASDAQ: NBSE ) -15% on equity offering . More news on: NeuBase Therapeutics, Inc., Yield10 Bioscience, Inc., Blueprint Medicines Corporation, Stocks on the move, , Read more ...
Gainers: Yield10 Bioscience (NASDAQ: YTEN ) +68% . More news on: Yield10 Bioscience, Inc., Aytu BioScience, Inc., Avadel Pharmaceuticals plc, Stocks on the move, , Read more ...
Axsome Therapeutics (NASDAQ: AXSM ) +44% as Avadel Pharmaceuticals gains 34% on positive data on lead drug. More news on: Axsome Therapeutics, Inc., Avadel Pharmaceuticals plc, Yield10 Bioscience, Inc., Stocks on the move, , Read more ...
WOBURN, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has obtained a positive response from USDA-APHIS’s Biotechnology Regulatory Services (BRS) for its CRISPR genome-edited C3007 trait in...
The following slide deck was published by Yield10 Bioscience, Inc. in conjunction with their 2019 Q4 earnings Read more ...
Yield10 Bioscience, Inc. (YTEN) Q4 2019 Earnings Conference Call March 19, 2020, 04:30 PM ET Company Participants Lynne Brum - VP of Planning and Corporate Communications Oliver Peoples - President and CEO Kristi Snell - VP of Research and CSO Chuck Haaser - Chief Accounting Of...
News, Short Squeeze, Breakout and More Instantly...
Yield10 Bioscience Inc. Company Name:
YTEN Stock Symbol:
NASDAQ Market:
- Nufarm to pay up to USD $5 million in consideration for the license -The parties will negotiate the sale of essentially all of Yield10’s assets to Nufarm WOBURN, Mass. and WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“...
WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that U.K.-based Rothamsted Research Limited (“Rothamsted”)...
- EPA approved an amendment to the label of INTERLINE herbicide to include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield1...